Evaluation of anti-fibrotic activity of ethanolic extract of Nelumbo nucifera gaertn. Seed against doxorubicin and unilateral ureter obstruction-induced renal fibrosis

R Rushendran 1,  
T Mamatha 1,  
J Roja 1,  
Department of Pharmacology, Krishna teja pharmacy college, Tirupati, Andhra Pradesh, India
Professor, HOD, Department of Pharmacology, Krishna teja pharmacy college, Tirupati, Andhra Pradesh, India
Department of Pharmacognosy, Sree Vidyanikethan Pharmacy College, Tirupati, Andhra Pradesh, India
JPCCR 2017;11(1):66–75
The study were undertaken to evaluate anti-fibrotic activity of ethanolic extract of Nelumbo nucifera seed (NNSEE) against doxorubicin and Unilateral Ureter Obstruction-induced renal fibrosis.

Material and Methods:
Animals were divided into five groups with six animals in each group, i.e. Normal, Positive control, Standard (Pirfenidone 200mg/kg), Test-I (NNSEE 200mg/kg), and Test-II (NNSEE 400mg/kg). Renal fibrosis was developed by doxorubicin and UUO-induced methods. After induction of renal fibrosis, profibrotic responses in biochemical parameters were observed, e.g. BUN, serum creatinine levels were elevated, while total protein and GFR levels decreased. Antioxidant (SOD and CAT) levels are also attenuates and hyalinized glomeruli cells, damage to tubular cells were noted in histopathology, which are all responsible for the development of renal fibrosis.

The result showed that the anti-fibrotic activity of NNSEE at a dose of 200 and 400mg/kg b.wt was comparable with the standard treatment 200mg/kg b.wt of pirfenidone (anti-fibrotic drug). These data supplemented with histopathological studies of rat kidney sections. NNSEE had reversed all the manifestation of renal fibrosis.

Results of the study indicate that the NNSEE has potent anti-fibrotic activity, as well as antioxidant property, in dose dependent manner that may be due to the presence of major phytochemical constituents such as alkaloids, polyphenols.

R Rushendran
epartment of Pharmacology in Krishna teja pharmacy colleg
1. Hideki Yokoi, Suqawara, Mukoyama, Mori, Makino, Suqanami, Naqae, Yahata, Fujinaga, Tanaka, Nakao.Role of connective tissue growth factor in profibrotic action of transforming growth factor-β: A potential target for preventing renal fibrosis. American Journal of Kidney Disease 2011; 38(4) (suppl 1): 134–138.
2. Patricia silva 2015, Death report of kidney failure linked to fibrosis. Available from http://ckdnews.com/2015/08/10/study-reports-new-potential-therapy-kidney-fibrosis-ckd/.
3. ArvindAgarwal, Deepika Bora, ChanderpriyaAgarwal, Ratendra Kumar and VeermaramChoudhary. CNS stimulant and antidepressant activity of seeds of Abelmoschusesculentus in rats. Bull. Pharm. Res. 2015; 5(2): 1–4.
4. SirishaChowdary. Neuropharmacological Screening of the ethanolic extract of Nelumbo nucifera seeds. International Journal in Pharmacy and Biotechnology 2013; 1(5): 635–642.
5. Gupta. Drug screening methods (preclinical evaluation of new drugs). International Students Edition (2nd edition) 2009; chapter 11: 185–193.
6. Claiborne and Malinowski and Fridovich. Purification and characterization of hydroperoxidase II of Escherichia coli B. The Journal of Biological Chemistry 1979; 254(22): 11664–11668.
7. Mishra and Fridovich. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase; The Journal of Biological Chemistry; 247: 3170–3175.
8. Oka, Suwitra and Soebadi. Obstructive nephropathy of kidney stone: The role of caspase-3, TGF-β and TNF-α in kidney fibrosis. Bali Medical Journal 2014; 3(2): 104–111.
9. Campanholle, Liqresti, Gharib and Duffield. Cellular mechanism of tissue fibrosis: Novel mechanism of kidney fibrosis. American Journal of Physiology 2013; 304: 591–603.
10. Decleves& Sharma. Novel targets of anti-fibrotic and anti-inflammatory treatment in CKD. Nature Reviews Nephrology 2014; 10: 257–267.
11. Leung, Tonelli and James. Chronic kidney disease following acute kidney injuryrisk and outcomes. Nat. Rev. Nephrol 2013; 9: 77–85.
12. Bharadwaj and Modi. A review on therapeutic potential of Nelumbo nucifera: the sacred lotus. International Journal of Pharmaceutical Sciences and Research 2016; 7(1): 42–54.
13. PrashantTiwari, Bimlesh Kumar, MandeepKaur and Harleen Kaur. Phytochemical screening and extraction: A Review. Internationale Pharmaceutica Sciencia 2011; 1(1): 98–106.
14. Vidya, Ramesh, Rajashekar, Meghana, Nazeer. The nephroprotective activity of methanolic extracts of Phyllanthusacidus leaves against gentamycin induced nephrotoxicity in experimental rodents. International Journal of Pharmacy and Pharmaceutical Sciences 2013; 5(4): 209–213.
15. Klahr and Morrissey. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002; 283: 861–875.
16. Luis Pimentel, Angel Montero, Susheng Wang, Igor Yosipiv, Samir Dhar and Manuel Martinez Maldonado. Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral obstruction. Kidney International 1995; 48(4): 1247–1253.
17. Manimala, Karpagam, Deecaraman, Clement Atlee, PurushothPrabu. Evaluation of nephroprotective and antioxidant activity of ethanolic extracts of Momordicadioica leaves. Der Pharmacia Lettre Journal 2015; 7(4): 153–156.
18. Davies KJ. Oxidative stress: The paradox of aerobic life. Biochemical Society Symposium 1995; 61: 1–31.
19. Bannister, Rotilio, Bannister. Aspects of the structure, function and applications of superoxide dismutase. CRC Critical reviews in Biochemistry 1987; 22(2): 111–80.
20. Chelikani, Fita and Loewen. Diversity of structures and properties among catalases. Cellular and Molecular Life Sciences 2004; 61(2): 192–208.
21. Rhee, Ho Zoon Chae and Kanghwa Kim. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free radical biology and Medicine 2005; 38(12): 1543–1552.
22. CsabaImreSzalay, KatalinErdelyi, Gabor Kokeny, EnikoLajtar, Maria Godo, CsabaRevesz, TamasKaucsar, Norbert Kiss, Marta Sarkozy, Tamas Csont, Tibor Krenacs, Gabor Szenasi, Pal Pacher and Peter Hamar. Oxidative or Nitrative stress and inflammation drive progression of doxorubicin induced renal fibrosis in rats as revealed by comparing a normal and a fibrosis resistant rat strain. Journal Pone 2015; 10(6): 1–17.
23. Alton Farris and Robert Colvin. Renal interstitial fibrosis: Mechanism and evaluation. Current Opinion in Nephrology and Hypertension 2012; 21(3): 289–300.